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Pro-Apoptotic Protein Noxa Regulates Memory T Cell
Population Size and Protects against Lethal
Immunopathology
Felix M. Wensveen,* Paul L. Klarenbeek,*,† Klaas P. J. M. van Gisbergen,*,‡
Maria F. Pascutti,*,x Ingrid A. M. Derks,* Barbera D. C. van Schaik,{ Anja ten Brinke,‖
Niek de Vries,† Ðurdica Cekinovic´,# Stipan Jonjic´,# Rene´ A. W. van Lier,*,‡ and
Eric Eldering*
Memory T cells form a highly specific defense layer against reinfection with previously encountered pathogens. In addition,
memory T cells provide protection against pathogens that are similar, but not identical to the original infectious agent. This is
because each T cell response harbors multiple clones with slightly different affinities, thereby creating T cell memory with a certain
degree of diversity. Currently, the mechanisms that control size, diversity, and cross-reactivity of the memory T cell pool are
incompletely defined. Previously, we established a role for apoptosis, mediated by the BH3-only protein Noxa, in controlling
diversity of the effector T cell population. This function might positively or negatively impact T cell memory in terms of function,
pool size, and cross-reactivity during recall responses. Therefore, we investigated the role of Noxa in T cell memory during acute
and chronic infections. Upon influenza infection, Noxa2/2 mice generate a memory compartment of increased size and clonal
diversity. Reinfection resulted in an increased recall response, whereas cross-reactive responses were impaired. Chronic infection
of Noxa2/2mice with mouse CMV resulted in enhanced memory cell inflation, but no obvious pathology. In contrast, in a model of
continuous, high-level T cell activation, reduced apoptosis of activated T cells rapidly led to severe organ pathology and premature
death in Noxa-deficient mice. These results establish Noxa as an important regulator of the number of memory cells formed during
infection. Chronic immune activation in the absence of Noxa leads to excessive accumulation of primed cells, which may result in
severe pathology. The Journal of Immunology, 2013, 190: 1180–1191.
A
fter a pathogen has been successfully cleared from the
body, the adaptive immune system forms immunological
memory cells that provide long-lasting protection against
reinfection. Sufficient numbers of memory cells must be formed to
counter the reinfecting agent in a short enough time to prevent its
spread and replication, to achieve efficient protection. In contrast,
the maximum size of the memory cell pool must be restricted to
prevent excessive immune activation and pathology upon rein-
fection (1). In addition to population size, clonal diversity of the
memory cell pool must be controlled to ensure appropriate ef-
fectiveness of recall responses. Previously, it has been shown that
clonal diversity of the memory cell pool roughly reflects that of
the effector cell response, suggesting strong clonal selection (2).
However, a too restricted specificity of the memory cell pool
appears to be counterproductive (3). As many pathogens, such as
HIV and seasonal influenza, rapidly accumulate point mutations,
they may no longer be recognized by the memory cell pool when
the number of epitopes that is recognized is too small. Indeed,
studies both in humans and mice indicate that increased clonal
diversity of the memory cell pool provides enhanced protection
(4, 5). Mechanisms are therefore in place to ensure an appro-
priate size of the memory pool, whereas maintaining a certain
level of diversity.
Proper control of cell death plays an important role in the
control of memory T cell formation and reactivation (6, 7). Both
death-receptor–mediated apoptosis and the mitochondrial or in-
tracellular cell death pathway have been implicated in memory
T cell biology (8, 9). Deregulation of cell death pathways greatly
affects the number of memory T cells formed. Mice deficient for
proapoptotic Bim and Fas accumulate large numbers of memory
T cells after lymphocytic choriomeningitis virus infection (10,
11). Upregulation of Bcl-2 is essential for IL-7–mediated mem-
ory T cell survival (12). The role that other proapoptotic and
antiapoptotic molecules play in memory cell survival remains
relatively unknown.
A prominent candidate that potentially regulates memory cell
formation is the pro-apoptotic protein Noxa (encoded by Pmaip1).
During priming in the lymph node (LN), T cell activation, sur-
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vival, and effector pool size are strictly limited by the availability
of Ag, costimulatory molecules, nutrients, and cytokines (13).
Even in the presence of all these factors, outgrowth of some ac-
tivated T cells is favored over others, based on TCR affinity (14).
Previously, we have shown that expansion and persistence of low-
affinity effector cells is inhibited via competition-based apoptosis
that mediates clonal dominance of high-affinity clones via the
termination of low-affinity T cells (15). TCR affinity influences
stability of the prosurvival molecule Mcl-1 via an IL-2R–mediated
signaling loop. T cells lacking Noxa, the antagonist of Mcl-1 (16),
therefore have a competitive advantage during priming, resulting
in the survival and recruitment of increased numbers of low-affinity
clones into the effector cell pool. This results in decreased numbers
of high-affinity cells and reduced Ag responsiveness of the effector
T cell pool as a whole. Currently, it is unknown whether Noxa
mediates similar effects during the formation of memory T cells.
In this study, we investigated how the absence of Noxa affects
the formation, maintenance, and recall capabilities of memory
T cells. We find that Noxa ablation results in enhanced diversity of
the memory cell compartment and increased absolute memory cell
numbers upon influenza infection. As a result of increased memory
cell numbers, Noxa2/2 mice form enlarged recall responses and
have increased memory inflation during chronic mouse CMV
(mCMV) infection. In a transgenic model of persistent T cell
activation, effector T cell accumulation ultimately led to severe
organ pathology and premature death in mice deficient for Noxa.
Our data show that control of memory precursor (MP) cell
numbers via Noxa-mediated apoptosis is essential to prevent
excessive immune responses upon reinfection.
Materials and Methods
Mice
C57BL/6J (B6) and B6 Ly5.1+ (B6.SJL-Ptprca Pepcb/BoyJ) JAX mice
were purchased from Charles River and kept as breeding colonies in our
local animal facility. Only these mice, which were kept under identical
conditions as our transgenic and gene-targeted mice, were used as wild-
type (WT) controls in our experiments. Noxa2/2 mice (C57BL/6-
Pmaip1tm1Ast/J) were a kind gift from Dr. A. Strasser (Walter and
Eliza Hall Institute, Melbourne, Australia) and provided by Dr. M. Serrano
(Spanish National Cancer Research Centre, Madrid, Spain). Noxa5.1 mice
were generated by crossing Noxa2/2 mice with B6 Ly5.1+ mice from our
in-house colony. B cell–specific CD70TG mice were generated as previ-
ously described (17). Noxa70 mice were generated by crossing Noxa2/2
mice with CD70TG mice. Mice were used at 6–12 wk of age, unless stated
otherwise, were age and sex matched within experiments, and were han-
dled in accordance with institutional and national guidelines. All mice
were either generated in B6 mice or backcrossed at least 10 times on this
background.
Viral infection
Influenza A virus strains used were A/PR/8/34 (PR8, H1N1) (18), A/Aichi/
HK/2/68 (HK2/68, H3N2) (19), and A/HKx31 (HKx31, H2N3; this is
a recombinant of the PR8 and HK2/68 strains) (20). Viruses were gen-
erated in LLC-MK2 cells, and 50% tissue culture-infective dose was
determined in WT B6 mice as previously described (21). Mice were
infected intranasally with 10 3 50% tissue culture-infective dose under
general anesthesia. Bacterial artificial chromosome–derived mCMV strain
MW97.01, which was experimentally shown to be identical to the WT
Smith strain (22), was generated in primary mouse embryonic fibroblasts
according to standard protocol (23). PFUs were determined by standard
plaque assay on mouse embryonic fibroblasts, and 5 3 105 PFUs per mouse
were injected i.p.
Flow cytometry
Single-cell suspensions were obtained by mincing the specified organs
through 40-mm cell strainers (Becton Dickinson). Erythrocytes were lysed
with an ammonium chloride solution (155 mM NH4Cl, 10 mM KHCO3,
and 1 mM EDTA), and cells were subsequently counted using an auto-
mated cell counter (Scha¨rfe System). Cells (5 3 105 to 5 3 106) were
collected in staining buffer (PBS with 0.5% BSA; Sigma) and stained
for 30 min at 4˚C with Abs in the presence of anti-CD16 and anti-CD32
(clone 2.4G2), anti-mouse FcgRII and FcgRIII (a kind gift of Louis
Boon, Bioceros, Utrecht, The Netherlands). mAbs against CD3 (145-
2C11), CD4 (L3T4), and CD62L (Mel-14) were bought from BD Bio-
sciences. Abs against CD8 (53.6.7), CD44 (IM7), CD45.1 (A20),
CD127 (A7R34), IFN-g (XMG1.2), and KLRG1 (2F1) were bought
from eBiosciences. FACS experiments were performed on a FACSCali-
bur or FACSCanto (Becton Dickinson) and analyzed with FlowJo soft-
ware (TriStar). T cell subsets were sorted to .99% purity with a
FACSAria (Becton Dickinson). PE- or allophycocyanin-conjugated H2Db
and H2Kb tetramers were made by Sanquin (http://www.sanquin.nl). To
stain influenza-specific CD8 T cells, we loaded H2Db tetramers
with ASNENMETM (DbMETM; HKx31 and PR8) or ASNENMDAM
(DbMDAM; HK2/68). To stain mCMV-specific cells, we loaded H2Kb
tetramers with SCLEFWQRV (Kbm57), TVYGFCLL (Kbm139), and
RALEYKNL (KbmIE3).
Multiplex ligation-dependent probe amplification analysis
Total RNA was extracted using the TRIzol isolation method (Invitrogen).
mRNA levels were analyzed with the Apoptosis Mouse mRNA multiplex
ligation-dependent probe amplification (RT-MLPA) kit (MRC-Holland,
http://www.mlpa.com) according to the manufacturer’s instructions. Sam-
ples were run through a GeneScan and analyzed with GeneMapper (Applied
Biosystems GmbH; http://www.appliedbiosystems.com) and subsequently
Excel software (Microsoft) as described previously (15).
Flow cytometric measurement of intracellular proteins
To determine direct ex vivo cytokine production, we plated splenocytes at
1 3 106 cells/well in a 96-well round-bottom plate and stimulated with
10 ng/ml PMA and 1 mM ionomycin (Sigma) or with peptides
(ASNENMETM, SCLEFWQRV, RALEYKNL, and TVYGFCLL; Gen-
script, http://www.genscript.com) for 6 h at 37˚C. During the final 4 h,
1 mg/ml of the protein-secretion inhibitor brefeldin A (Sigma) was added.
Thereafter, cells were washed and stained with anti-CD4 or anti-CD8,
followed by fixation and permeabilization (Becton Dickinson). Cells
were then incubated for 30 min with fluorescently labeled Abs against
IFN-g, thoroughly washed, and analyzed by flow cytometry.
Adoptive transfer and in vivo cytotoxicity
For adoptive transfer, WT and Noxa2/2 mice (both CD45.1) were infected
intranasally with influenza PR8. Ten days postinfection, CD8+ T cells were
isolated from spleens by positive selection using the MACS cell separation
system (Miltenyi). Cells were injected i.v. in WT (CD45.2) recipient mice,
and contraction was followed in the blood. For in vivo cytotoxicity (see
Fig. 3C), splenocytes from naive WT (CD45.1) mice were isolated, divided
in four fractions, and labeled with carboxyfluorescein succinimidyl ester
(CFSE), 7-hydroxy-9H-(1,3-dichloro-9,9-dimethylacridin-2-one) (DDAO)
(both Molecular Probes), both, or nothing. Fractions were subsequently
incubated for 2 h with the viral peptides ASNENMETM (CFSE+),
SSLENFRAYV (DDAO+), and LSLRNPILV (CFSE+DDAO+) or the con-
trol peptide SIINFEKL (no dye) in RPMI, washed, and mixed in a 1:1:1:1
ratio. A total of 10 3 106 cells of this mixture was injected per mouse in
WT or Noxa2/2 recipients (CD45.2) that had been infected with influenza
50 d previously. As a readout for specific killing, the relative decrease of
viral-peptide pulsed cells, in comparison with control-peptide pulsed
cells, was measured within the CD45.1+ cell pool in the blood.
PCR and sequence analysis of TCR clones
Total RNAwas extracted from CD3+CD42CD8+DbMETM+ T cells, sorted
with a FACSAria (BD Biosciences) cell sorter, using the TRIzol (Invi-
trogen) isolation method, according to the manufacturer’s protocol. cDNA
was generated using SuperscriptII-RT and oligo-dT primers according to the
manufacturer’s protocol (#18064; Invitrogen). The CDR3 of the b-chain
was used as a unique tag for clonal expansions, as previously described (3,
24). The TCR of the DbMETM tetramer binding cells were amplified with
primers specific for the Vb8.3 gene segment (59-GCCTCCCTCGCGCC-
ATCA GTGCTGGCAACCTTCGAATAGGA-39) and the Constant segment
(59-AAGGAGACCTTGGGTGGAGT-39), using the following PCR con-
ditions: 4 ml cDNA (out of a total volume of 50 ml) was amplified in the
presence of 10 pmol of both primers, 1 mM MgCL2, 0.1 mM dNTPs, 13
Buffer B (Solis BioDyne, Tartu, Estonia), and 2 U Hotfire-Polymerase
(Solis BioDyne) in a volume of 40 ml. Amplification was performed on
a T3000 thermocycler (Biometra, Go¨ttingen, Germany) in 35 cycles (hot
start [96˚C for 15 min], then 403 [96˚C for 30 s, 60˚C for 1 30 s, 72˚C for
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60 s], and 10 min at 72˚C). Amplification products were purified using
AMPure SPRI beads (Agencourt Bioscience, Beverly, MA). The primers
were tailed with the primer A and primer B sequences that allow high-
throughput sequencing using a Genome Sequencer FLX (Roche Diag-
nostics, Mannheim, Germany). CDR3 regions were identified as described
earlier (24). Preparation of the samples and sequencing was performed
according to the manufacturer’s protocol for amplicon sequencing on the
FLX platform.
Immunohistochemistry
For histochemical analysis, formalin-fixed and paraffin-embedded sections
were stained with H&E. For immunohistochemical analysis, sections were
stained with primary Abs against cleaved caspase-3 (Cell Signaling) and
subsequently with PowerVision Anti-Rabbit Poly-HRP (Immunologic).
Cells were visualized with diaminobenzidine (Sigma-Aldrich) and coun-
terstained with hematoxylin.
Statistical analysis
Statistical analysis of the data were performed using the unpaired Student
t test, Wilcoxon Mantel–Cox test, one-way ANOVA test, or Mann–Whit-
ney U test where applicable. Asterisks denote significant differences (*p ,
0.05, **p , 0.005, ***p , 0.0005).
Results
Noxa limits CD8+ memory T cell numbers
Previously, we observed Noxa induction after in vitro stimulation
of naive CD8 T cells (15, 25). To investigate whether Noxa may
also be expressed during memory T cell formation, we analyzed
mRNA levels of Noxa and 39 other apoptosis genes ex vivo in
CD8 T cell subpopulations. Mice were infected with PR8 virus
and 10 days later, splenic short-lived effector cells (SLECs) and
MP cells were sorted. mRNA expression was compared with that
of naive T cells and central memory (CM) cells via RT-MLPA
analysis. For the prosurvival Bcl-2 proteins, expression of Bcl-
XL was higher in all Ag-experienced T cell subsets compared
with naive cells (Fig. 1A). In accordance with previous findings,
specifically SLECs had reduced levels of Bcl-2 (26). Interestingly,
prosurvival molecule BCL2A1 and its antagonist Noxa, which we
and others had previously shown to be induced in activated T cells
(15, 25, 27), are also highly expressed in MP cells, whereas their
mRNA levels are lower in central memory cells. mRNA ex-
pression of Puma, in contrast, followed a reciprocal pattern, and
its expression is higher in central memory cells (Fig. 1A).
The similar high level of Noxa expression in MPs as in SLECs
prompted us to investigate memory cell formation in Noxa-
deficient mice. WT and Noxa2/2 mice were infected with influ-
enza A/HKx31 (HKx31) or PR8, and memory cell formation was
followed over time. As previously described (15), size and affinity
of the Ag-specific effector cell pool was reduced in Noxa-deficient
animals. At the peak of infection, less DbMETM+ CD8 T cells
were observed in the blood of Noxa2/2 mice (Fig. 1B). In addi-
tion, the mean fluorescent intensity (MFI) of tetramer binding,
which was previously shown to be a reliable measure of TCR
affinity (15), was reduced in Noxa2/2 effector cells (Fig. 1C).
Interestingly, at this time point postinfection, no differences in
numbers or tetramer binding were observed between MP pop-
ulations (Fig. 1C). In contrast, DbMETM+ CD8 T cell numbers
were increased in Noxa2/2 mice after 1 mo of infection and at
later time points. At these time points, most influenza-specific
SLECs has died and almost all cells have a CD127+KLRG12
memory phenotype (28). Indeed, Noxa-deficient mice had in-
creased numbers of flu-specific CD8 T cells displaying a memory
phenotype at late time points postinfection, whereas no differ-
ences in the number of SLECs were observed (Fig. 1D, 1E). The
increase in flu-specific central and effector memory populations
was also observed in the spleen and mediastinal LN of Noxa2/2
mice (Fig. 1F, 1G), suggesting that Noxa restricts memory cell
numbers within secondary lymphoid tissues. To investigate
whether maintenance of memory cells was affected, we quan-
tified decay of Ag-specific cells between days 28 and 66 post-
infection. The t1/2 of Ag-specific cells was not significantly
different between WT and Noxa2/2 cells (WT: 71 6 33 d,
Noxa2/2: 89 6 30 d; p = 0.58), indicating that Noxa deficiency
affects memory formation, rather than memory cell maintenance
at later time points.
To investigate whether Noxa impacts recall responses, we
performed a challenge experiment, as previously described (29).
WT and Noxa-deficient mice were infected intranasally with
the influenza strain HKx31. This virus is a recombinant that
expresses the internal components of PR8, but the cell surface
proteins of A/Aichi/HK/2/68 (HK2/68) (20). Therefore, reinfec-
tion with PR8 induces a strong memory CD8 T cell response,
whereas no Abs recognize this virus. Two months after HKx31
infection, animals were reinfected with PR8 and CD8 T cell
responses were analyzed after 9 d. Noxa2/2 mice generated an
Ag-specific CD8 T cell response that was significantly larger than
that of WT mice, both in spleen and lungs (Fig. 1H). However,
both before and after reinfection, Noxa2/2 mice had roughly two
times more Ag-specific cells within their CD8 T cell pool. This
suggests that the increased recall response in Noxa-deficient mice
is solely the result of increased memory cell numbers and not of
per cell differences in recall capacity. Thus, Noxa limits the size of
the memory pool, and thereby the size of the CD8 T cell recall
response.
Noxa contributes to selection of CD8+ T cell clones during
primary but not secondary responses
Previously, we have shown that Noxa mediates selection of high-
affinity clones during primary effector responses (15). Enhanced sur-
vival of subdominant clones may therefore be responsible for the
increase in memory cells in Noxa2/2 mice. To examine whether
Noxa also affected selection of clones in memory and recall re-
sponses, we analyzed the clonal diversity of DbMETM+ CD8
T cells. WT and Noxa-deficient mice were infected with influenza
PR8 virus, and DbMETM+ CD8 T cells were sorted after 84 d.
Clonal TCR analysis was performed using next generation se-
quencing. CDR3 regions were compared in T cells that use the
Vb8.3 gene fragment (3, 24). The response against the ASNEN-
METM epitope is dominated by a Vb8.3-restricted population
containingmany public clones, which allows direct comparison (30).
On average 6194 (6409) Vb8.3 sequences were analyzed per
animal. Clones retrieved less than three times were excluded
from analysis, to prevent “pollution” with naive clones. In both
groups, the majority of reads was derived from a limited number
of expanded clones (sequences retrieved .50 times). Together,
750 clones were detected in Noxa2/2 mice, compared with only
368 clones in WT animals. In line with these findings, the median
frequency of clones in Noxa2/2 mice was significantly lower
compared with that in WT mice (Fig. 2A). Further analysis
revealed that this difference was primarily caused by an increase
of low-frequency clones (3–11 copies/clone; Fig. 2B).
Next, the diversity of the recall populations was compared
between WT and Noxa2/2 mice. Mice were infected with in-
fluenza HKx31 and reinfected with PR8 after 2 mo. DbMETM+
CD8 T cells were sorted after 9 d, and Vb8.3 T cells were an-
alyzed by deep sequencing. Strikingly, the clonal variety within
the CD8 T cell population was very much reduced after recall
compared with the memory phase (Fig. 2C, 2D). In all animals,
the vast majority of reads consisted of up to three highly ex-
panded clones. In this phase of the response, no significant dif-
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ferences in clonal frequency were observed between WT and
Noxa2/2 animals (Fig. 2D).
Our data show that Noxa is redundant for selection of T cell
clones from the memory pool during reinfection with a patho-
gen bearing the same epitope. This is in contrast with its important
role in selection of naive cells into the effector and, to a lesser
extent, into the memory repertoire (15). However, increased clonal
diversity of the memory cell pool could not completely explain the
increased number of memory cells in Noxa2/2 mice, suggesting
that Noxa has a role beyond affinity-based selection.
Noxa ablation has a minor effect on the quality of memory and
recall responses
The increased diversity of the memory cell repertoire of Noxa2/2
mice prompted us to investigate whether the quality of memory
cells was affected in these animals. Previously, we have shown
that Noxa expression exerts selective pressure on the flu-specific
CD8 T cell population to enhance the affinity of the primary
effector response (15). Surprisingly, the MFI of tetramer binding
was not different between flu-specific memory cells of WT and
Noxa2/2 mice (Fig. 3A). To test Noxa-deficient memory cells in
FIGURE 1. Noxa limits the number of CD8+ memory T cells. (A) Naive (CD3+CD42CD8+CD44dimCD62L+), central memory (CD3+CD42CD8+
CD44brightCD62L+), MP cells (CD3+CD42C8+DbMETM+KLRG12), and SLECs (CD3+CD42CD8+DbMETM+KLRG1+) were sorted to.99% purity from
splenocytes of mice infected 10 d previously with influenza PR8. mRNA expression of proapoptotic and antiapoptotic regulators was analyzed by RT-
MLPA. Differential gene expression is represented in a heat map after log transformation of expression levels (scale is from 22.5 to 2.5), relative to
averaged values of naive cells at day 0 (n = 3). Granzyme B (GZMB) expression values for naive cells were below detection levels. For calculations, these
were set at an arbitrary lower threshold value of 0.02 per group. Notably, GZMB levels were 11- (63,5) and 81-fold (626) higher in SLECs than in MP and
CM cells, respectively. (B–E) Mice were infected with influenza virus HKx31, and Ag-specific T cell responses were followed over time in the blood. (B)
Relative number of DbMETM+ cells as a percentage of CD8 T cells. (C) Quantification of the MFI of DbMETM+ SLEC (CD8+DbMETMCD1272KLRG1+;
left panel) and MP (CD8+DbMETM+CD127+KLRG12; right panel) cells 8 d postinfection. (D) Relative number of DbMETM+ SLECs as a percentage of
CD8 T cells. (E) Relative number of DbMETM+ MP cells as a percentage of CD8 T cells. (F and G) Mice were infected with influenza PR8, and 84 d
postinfection, Ag-specific cells were analyzed. Absolute numbers of Ag-specific memory cells in (F) spleen and (G) mediastinal LNs. (H) Mice were
infected with influenza HKx31 and reinfected with PR8 after 66 d (n = 8 per genotype). Absolute numbers of DbMETM+ CD8 T cells in the spleen and
lungs of mice, 8 d after reinfection. *p , 0.05, **p , 0.005 (Student t test). CM, central memory (CD8+DbMETM+CD44brightCD62L+); EM, effector
memory (CD8+DbMETM+CD44+CD62L2).
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a functional assay, we restimulated splenocytes of WT and
Noxa2/2 mice, infected 84 d previously, in vitro with limiting
concentrations of viral peptides and analyzed IFN-g production.
We observed that Noxa2/2 memory T cells were similarly
(SSLENFRAYV) or only slightly less (ASNENMETM) respon-
sive to decreasing doses of Ag (Fig. 3B). This suggests that Noxa
only modestly increases the affinity of memory T cells. This is in
accordance with the notion that, even though the Ag-specific
memory population of Noxa2/2 mice contained two times more
clones, these cells represented only ∼10% of the total number of
tetramer-binding memory cells (Fig. 2B). Apparently, this number
is too small to have a measurable impact on the peptide respon-
siveness of the memory cell pool as a whole. To test the capacity
of Noxa-deficient memory T cells to clear infected cells, an in vivo
cytotoxicity assay was performed. Splenocytes of naive congenic
mice (CD45.1) were pulsed with the viral peptides ASNEN-
METM, SSLENFRAYV, and LSLRNPILV to mimic viral infec-
tion, or with the control OVA peptide SIINFEKL. Pulsed cells
were differentially labeled with DDAO, CFSE, or both and
injected in WT and Noxa2/2 mice (CD45.2) that had been
infected with influenza virus 50 d previously. ASNENMETM and
SSLENFRAYV pulsed cells were cleared very efficiently, which
corresponds with their previously reported immunodominance in
antiviral CD8 T cell responses (31). Clearance of pulsed cells was
not reduced and even slightly increased in Noxa2/2 mice (Fig.
3C). Together, our data indicate that after influenza infection,
Noxa2/2 mice form increased memory cell numbers. These cells
are of sufficient affinity to generate a comparable response as mem-
ory cells of WT mice.
Subsequently, the quality of the recall response was investigated.
Mice were infected with HKx31, and after 2 mo reinfected with
PR8 and analyzed 8 d later. In accordance with the increased
number of DbMETM binding cells, compared with WT mice,
Noxa2/2 animals showed significantly higher numbers of CD8+
T cells producing IFN-g after in vitro restimulation with
ASNENMETM peptides (Fig. 3D). Next, the Ag affinity of these
cells was assessed. During acute infection, significantly reduced
DbMETM staining was found for Noxa-deficient T cells after
influenza infection (Fig. 3E, top panels). However, when the MFI
of T cells was analyzed at the peak of the recall response, this
difference between WT and Noxa-deficient mice was no longer
observed (Fig. 3E, bottom panels). Restimulation with limiting
concentrations of viral peptides and analysis of IFN-g responses
did not reveal differences in Ag responsiveness between secondary
effector cells of WT and Noxa2/2 mice (Fig. 3F). The equal left-
shift (and thus enhanced affinity) of the WT and Noxa2/2 curves
compared with those of the primary response (Fig. 3B, bottom
panel) is in accordance with similar narrowing of the Ag-specific
repertoire during recall (Fig. 3C, 3D).
These findings indicate that affinity-based selection of long-
term memory CD8 T cell clones is not as strongly dependent
on Noxa as selection of primary effector cells. Moreover, Noxa
does not have an essential role in affinity-based selection of
secondary effector cells during homologous recall responses.
Noxa enhances cross-reactive CD8 T cell responses
We questioned whether the role of Noxa in clonal selection during
recall responses was not observed, because we used a model in
which dominant clones preferentially expand from a memory
repertoire that is preselected on the same epitope. To increase
interclonal competition between memory cells, we therefore set up
a cross response, in which memory cells respond to an epitope they
have not encountered previously (3).
WT and Noxa2/2 mice were infected with influenza PR8 virus,
and reinfected with the heterologous influenza virus HK2/68. The
latter virus contains the immunodominant epitope ASNENMDAM
that is distinct from ASNENMETM, the immunodominant epitope
of PR8. Infection with one virus generates memory cells of which
a minor fraction is able to recognize both epitopes. Low-frequency
clones from this population generate the cross-reactive response
upon reinfection with the other virus (3). The presence of cross-
reactive cells was investigated using tetramers for both epitopes
FIGURE 2. After influenza infection, Noxa2/2 mice show higher
numbers of marginally expanded clones in the CD8+ memory T cell
compartment. (A and B) DbMETM+ CD8 T cells were sorted to .99%
purity 84 d after influenza PR8 infection, and Vb8.3 gene fragments were
analyzed by deep sequencing. On average, 6194 reads (6409) were ana-
lyzed per mouse (WT: n = 3, Noxa2/2: n = 3). (A) Frequency of individual
clones as a percentage of total reads per genotype. Percentages were used
to compensate for differences in clones sequenced per mouse. Shown are
pooled data from three mice per genotype. Clones that were retrieved only
one to two times (below the dotted line) were excluded from this analysis
to prevent “pollution” by naive cells. Arrows indicate medians. (B) Clones
were divided in six categories, based on the frequency with which they
were retrieved (1–2 times, 3–10 times, 11–20 times, 21–50 times, 51–700
times, or .700 times). Relative contribution of each of these categories to
the total number of reads is given. (C and D) DbMETM+ CD8 T cells were
sorted to .99% purity, 9 d after secondary infection with influenza PR8,
65 d after primary infection with influenza HKx31. Vb8.3 gene fragments
were analyzed by deep sequencing. On average, 5954 reads (6381) were
analyzed per mouse (WT: n = 3, Noxa2/2: n = 3). (C) Frequency of in-
dividual clones as a percentage of total reads per genotype. Percentages
were used to compensate for differences in clones sequenced per mouse.
Shown are pooled data from three mice per genotype. Clones that were
retrieved only one to two times (below the dotted line) were excluded from
this analysis to prevent “pollution” by naive cells. Arrows indicate
medians. (D) Clones were divided in six categories as in (B). Relative
contribution of each of these categories to the total number of reads is
given. ***p , 0.0001 (Mann–Whitney U test).
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(DbMETM and DbMDAM) with different fluorescent labels. As
observed previously (15), upon primary infection, Noxa2/2 mice
generated reduced numbers of DbMETM+ cells, which were also
of decreased affinity (Fig. 4A, 4B). In contrast, no differences
were observed in the number of cross-reactive cells between WT
and Noxa2/2 mice (Fig. 4C). When binding affinities were com-
pared between DbMETM+ subsets, Noxa-deficient DbMETM+Db
MDAM2 single-positive cells bound DbMETM with significantly
reduced intensity. DbMETM+DbMDAM+ double-positive cells of
these mice bound both tetramers with equal intensity as WT cross-
reactive cells (Fig. 4D, 4E).
When cross-reactive memory populations were compared on day
60 postinfection, a small increase of cross-reactive cells as a
fraction of total Ag-specific cells was observed in Noxa2/2 mice,
but this difference was not significant (Fig. 4F). Also, affinity di-
fferences were observed in DbMETM+DbMDAM2 cells, but not in
DbMETM+DbMDAM+ cells (Fig. 4G, 4H). Markedly, in contrast
with recall responses against the same epitope, reinfection with the
cross-reactive virus resulted in significantly reduced effector cell
numbers in Noxa-deficient mice compared with WT mice (Fig. 4I,
4J). Thus, similar to naive cells, memory cells require Noxa for
selection into effector responses if the precursor frequency of high-
affinity cells is low.
Noxa controls memory T cell formation and not T cell
contraction
Next to the effect of Noxa on the quality of the memory response,
Noxa also limited the size of the total memory population. The
increased memory formation observed in Noxa2/2 mice may have
resulted from delayed T cell contraction after antigenic clearance.
Contraction can be investigated by following the survival of flu-
specific cells after adoptive transfer into pathogen-free animals.
WT and Noxa2/2 mice (CD45.1) were infected with PR8 virus
and 10 d postinfection, total splenic CD8 T cells were isolated and
equal numbers of cells were injected into congenic (CD45.2)
naive hosts (Fig. 5A). Because of the abrupt lack of an inflam-
matory environment for the transferred virus-specific cells, direct
contraction of the Ag-specific pool ensues under these conditions
(32). Ag-specific donor T cells could be observed up to day 28,
after which their numbers declined below detection levels. During
this period, no difference was observed in the contraction of Ag-
specific cells between WT and Noxa2/2 cells (Fig. 5B). This
FIGURE 3. Noxa ablation has a minor effect on the quality of memory and recall responses. (A and B) Mice were infected with influenza PR8 and 84 d
postinfection, Ag-specific cells were analyzed. (A) Representative FACS plots of splenic DbMETM-specific CD8 T cells. Gated is for CD8+CD127+ cells.
(B) IFN-g production induced by varying doses of peptide in (top panel) SSLENFRAYV and (bottom panel) ASNENMETM restimulated CD8+ T cells,
relative to the level of cells stimulated with saturating (500 ng/ml) peptide. (C) WTor Noxa2/2 mice (CD45.2) were infected with influenza PR8. Fifty days
postinfection, splenocytes from naive mice (CD45.1) were fluorescently labeled, pulsed with the viral peptides ASNENMETM (METM), SSLENFRAYV
(SSLEN), LSLRNPILV (LSLR), or the control peptide SIINFEKL (OVA). Cells were injected in infected recipients, and clearance of viral peptide-pulsed
cells was measured after 18 h in the blood. (top panel) Fraction of pulsed cells as a percentage of total donor cells. (bottom panel) Representative FACS
plots of CD45.1+ cells before and 18 h after injection. (D–F) Mice were infected with influenza PR8 and reinfected with influenza HKx31 after 65 d (n = 8
per genotype). (D) Relative number of IFN-g–producing cells after in vitro restimulation with ASNENMETM peptides. (E) Representative FACS plots of
CD8 T cells stained with DbMETM (first infection) 10 d postinfection with influenza HKx31 or (second infection) 8 d after reinfection with influenza PR8.
Gated is for CD8+ cells. (F) IFN-g production induced by varying doses of peptide in ASNENMETM restimulated CD8+ T cells, relative to the level of cells
stimulated with saturating (500 ng/ml) peptide. *p , 0.05 (Student t test).
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argues against a role for Noxa in the contraction phase of the
antiviral response, which underlines previous findings after HSV
infection (33).
In the PR8-HKx31 influenza infection model, the relative in-
crease of Ag-specific cell numbers was identical between WT and
Noxa-deficient mice during the recall response (Fig. 1F). If in-
creased memory cell numbers are formed in Noxa2/2 mice during
priming, infection of recipient mice should result in increased
Noxa-deficient donor cell numbers in the earlier mentioned
adoptive transfer model. Therefore, 1 mo after transfer, recipient
mice were infected with PR8 virus. Noxa-deficient memory
T cells expanded significantly more than transferred WT cells both
in relative and absolute numbers. This effect was more pro-
nounced in the lungs, the site of viral replication, than in spleen,
blood, and LNs (Fig. 5C–E).
Together, these data show that Noxa plays a role in controlling
the number of memory cells that is formed early postinfection, but
does not affect contraction.
Noxa ablation leads to increased memory inflation during
chronic mCMV infection
In humans, boosting of the CD8 memory T cell pool is most
pronounced postinfection with chronic viruses such as CMV. CMV
causes a chronic, latent infection that is never cleared. After the
acute phase upon primary infection, CMV remains latently present
in its host, but is regularly reactivated, which causes flares of the
FIGURE 4. Noxa ablation reduces cross-reactive memory responses. Mice were infected with the ASNENMETM-epitope expressing influenza strain
PR8. Sixty days after primary infection, mice were reinfected with the ASNENMDAM-epitope expressing influenza strain HK2/68. Seven days after
secondary infection, mice were sacrificed and organs analyzed. (A–E) Analysis of Ag-specific cells 10 d after primary infection. (A) Number of DbMETM+
cells in the blood of infected mice, as a percentage of CD8 T cells. (B) Quantification of the intensity of DbMETM staining within the DbMETM+ CD8 T
cell pool. (C) Number of cross-reactive (DbMETM+DbMDAM+) cells as a percentage of DbMETM+ CD8 T cells. (D) Quantification of the intensity of Db
METM staining within the DbMETM+DbMDAM2 (left panel) and DbMETM+DbMDAM+ (right panel) CD8 T cell populations. (E) Quantification of the
intensity of DbMDAM staining within the DbMETM+DbMDAM+ CD8 T cell population. (F–H) Analysis of Ag-specific cells 60 d after primary infection.
(F) Number of cross-reactive (DbMETM+DbMDAM+) cells as a percentage of DbMETM+ CD8 T cells. (G) Quantification of the intensity of DbMETM
staining within the DbMETM+DbMDAM2 (left panel) and DbMETM+DbMDAM+ (right panel) CD8 T cell populations. (H) Quantification of the intensity
of DbMDAM staining within the DbMETM+DbMDAM+ CD8 T cell population. (I and J) Analysis of Ag-specific cells 7 d after secondary infection. (I)
Relative number of cross-reactive (DbMETM+DbMDAM+) cells as a percentage of CD8 T cells in the indicated organs. (J) Representative FACS plots of
peripheral blood CD8 T cells stained with tetramers. Gated is for CD8+ cells. *p , 0.05, **p , 0.005 (Student t test).
1186 Noxa REGULATES MEMORY T CELL FORMATION











antiviral response (34). This continuous boost of the immune
system results in a gradual increase of CMV-specific CD8 T cells,
a so-called memory inflation, which will ultimately comprise a
very significant percentage of the total CD8 T cell pool both in
humans and in mice (34).
To investigate the role of Noxa in this model of chronic infec-
tion, we studied WT and Noxa2/2 mice infected with mCMV and
CD8 T cell responses directed against three different viral H2Kb
epitopes: one epitope that only induces a CD8 response during the
acute phase of mCMV infection (m57816–824), one epitope that is
only immunodominant during memory inflation (IE3/m122416–475),
and one epitope that is present during both responses (m139416–423)
(35).
As reported previously 10 d postinfection with influenza virus,
mCMV infection did not result in a different number of CD8
T cells with an effector phenotype (CD44+CD62L2) during the
peak of the antiviral response (15). When Ag-specific cell num-
bers were quantified, modestly reduced numbers of CD8+ T cells
directed against m57 and m139 were observed in Noxa2/2 com-
pared with WT mice (Fig. 6A and data not shown). As expected,
no T cell response against IE3 was observed during acute infec-
tion. When the intensity of tetramer staining was assessed, a clear
reduction in tetramer binding was observed in Noxa2/2 mice for
the m57816–824 and m139416–423 epitopes (Fig. 6B, 6C). When
splenic T cells were restimulated in vitro on day 8 postinfection,
a clearly reduced affinity for the m57816–824 peptide also was
observed (Fig. 6D). As reported previously (15), no differences
were observed in expression levels of CD3 or TCRb in Noxa2/2
effector cells compared with WT cells, excluding enhanced TCR
downregulation as a cause of reduced tetramer staining (data not
shown). Together, these data indicate that, identical to influenza
infection, also during primary mCMV infection, Noxa-deficient
mice generate an effector T cell response of reduced affinity.
Subsequently, antiviral CD8 T cell formation was analyzed
during the chronic phase of mCMV infection, 4 mo postinfection.
In most analyzed organs, an increase in the absolute number of CD8
T cells was observed in Noxa2/2 mice (Fig. 7A). Phenotypic
analysis of these cells revealed an increase of both effector and
memory cells in these organs (Fig. 7B and data not shown). When
Ag-specific cells were investigated, in particular the inflationary
T cell pool directed against IE3416–475 was enlarged (Fig. 7C).
However, also the noninflationary m57816–824–specific pool, which
primarily had a memory cell phenotype (data not shown), was
increased in cell numbers. This corresponds with the observation
that Noxa-deficient mice have increased numbers of memory cells
after acute influenza infection. In contrast, the m139416–423–spe-
cific pool was not significantly increased.
Together, these data indicate that repetitive boosting of the
Ag-specific CD8 T cell pool during chronic mCMV infection
causes enhanced memory cell inflation in Noxa2/2 mice.
Persistent activation of the T cell compartment leads to lethal
pathology in Noxa2/2 mice
mCMV infection represents a model in which the CD8 T cell
compartment is continuously triggered by low doses of Ag. Other
infections, such as HIV infection in humans, lead to a constant
activation of the immune system because of the continuous
presence of high viral titers. Next, we investigated T cell responses
in Noxa2/2 mice under conditions of persistent immune activa-
tion. For this purpose, a transgenic mouse model was used. Co-
stimulation via CD70 and CD27 directs differentiation of naive
T cells into effectors (36). CD70TG mice possess an enlarged
fraction of effector T cells, which is driven by hyperrespon-
siveness to environmental Ag. These animals display signs of
chronic immune activation, strikingly resembling HIV infection
(37, 38). Therefore, Noxa2/2 mice were crossed with CD70TG
mice.
Under homeostatic conditions, CD70TG mice remain relatively
healthy for at least 6–8 mo but eventually die of opportunistic
infections as a result of T cell depletion (38). In stark contrast with
this gradual phenotype, Noxa2/2xCD70TG (Noxa70) mice dis-
played severe organ pathology, including splenomegaly, lung
damage, and liver fibrosis at an early age (Fig. 8A and data not
FIGURE 5. Enhanced recall
responses of Noxa2/2 CD8 T cells
results from increased formation of
memory cells early during the im-
mune response. WT and Noxa2/2
mice (CD45.1) were infected with
influenza PR8. Ten days later, total
CD8 T cells were isolated and
injected in naive WT recipients
(CD45.2). Thirty days after injec-
tion, recipient mice were infected
with influenza PR8 (n = 8 per ge-
notype). (A) Schematic representa-
tion of the experimental setup to
determine whether Noxa limits
memory CD8 T cell precursor
numbers during the priming phase of
influenza infection. (B) Donor Db
METM+ CD8 T cells in the blood of
recipient mice, as a percentage of
CD8 T cells. (C and D) Donor Db
METM+ CD8 T cells (C) in absolute
numbers and (D) as a percentage of
donor CD8 T cells. (E) Representa-
tive FACS plots of spleen cells
shown in (C). Gated is for CD8+
T cells. *p , 0.05 (Student t test).
The Journal of Immunology 1187











shown). Pathology culminated in premature death with a median
survival of only 16 wk (Fig. 8B). In contrast with CD70TG mice,
organ damage in Noxa70 mice was associated with accumulation
of T cells in spleen, liver, and lung, of which a large fraction had
an SLEC phenotype (Fig. 8C, 8D, and data not shown). Activated
caspase-3 staining in the spleen showed less apoptotic cells in
Noxa70 mice, indicating that the accumulation of lymphocytes
was the result of decreased apoptosis compared with CD70TG
FIGURE 6. Acute mCMV infection of Noxa2/2 mice leads to the formation of effector cells of reduced Ag affinity. (A–D) Mice were infected i.p. with
5 3 105 PFU mCMV, and Ag-specific responses were followed for three viral epitopes. Shown is one of three experiments (n = 8). (A) Number of (left
panel) Kbm139+, (middle panel) Kbm57+, and (right panel) KbIE3+ CD8 T cells, as a percentage of CD8 T cells. (B) Representative FACS plots of tetramer-
stained CD8 T cells 8 d postinfection. Gated is for CD8 T cells. (C) Quantification of the MFI of Dbm57+ cells 8 d postinfection. (D) IFN-g production
induced by varying doses of peptide in SCLEFWQRV restimulated CD8 T cells, relative to the level of cells stimulated with saturating (500 ng/ml) peptide.
*p , 0.05, ***p , 0.0005 (Student t test).
FIGURE 7. Noxa2/2 mice have increased memory inflation during chronic mCMV infection. Mice were infected i.p. with 53 105 PFU mCMV, and Ag-
specific responses were analyzed 140 d later. Shown is one of two experiments (n = 8). (A) Total number of CD8 T cells in various organs of infected mice.
(B) Total effector CD8 T cell numbers (KLRG1+) in organs of infected mice. (C) Total number of Ag-specific CD8 T cells in various organs of infected
mice. *p , 0.05, **p , 0.005 (Student t test).
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mice (Fig. 8E). As reported previously (38), CD70TG CD4 and
CD8 T cells produce high levels of IFN-g upon in vitro restim-
ulation. This phenotype was aggravated in absence of Noxa (Fig.
8F). Together, these data show that Noxa prevents leukocyte-
mediated organ pathology under conditions of chronic immune
activation.
Discussion
Upon activation, both effector and MP cell populations are subject
to control mechanisms that determine their appropriate magnitude
and diversity. In this article, we have shown that, in addition to
controlling formation of the effector T cell pool (15), the proap-
optotic BH3-only member Noxa is a mediator of memory cell
formation. Its ablation resulted in an increase of the overall size
and diversity of the antiviral memory T cell pool. This implies that
Noxa normally mediates elimination of MP cells that have ex-
panded beyond the amount that can be sustained by their envi-
ronment. Loss of Noxa was not beneficial for overall immunity
because it impaired cross-reactivity and resulted in severe im-
munopathology under conditions of chronic immune activation.
An open question is whether the role of Noxa during effector and
memory T cell formation comprises two different mechanisms or
represents two aspects of the same apoptotic checkpoint. Previ-
ously we showed that the Noxa/Mcl-1 axis mediates affinity-based
T cell selection dependent on IL-2R–mediated control of Mcl-1
stability. MP T cells also express the IL-2R (39, 40). However, IL-
15 appears to play a more prominent role in the formation and
maintenance of memory cells (41). Others have shown that Noxa
plays a role in the induction of NK cell apoptosis upon IL-15
deprivation (42). Thus, Noxa may also mediate IL-15–dependent
survival of MP T cells early during the immune response.
In line with this hypothesis, we present Noxa as a regulator of
activated T cell survival, specifically acting during the initial phase
of primary expansion. The physiological effects of its induction
will depend on the context; Noxa is induced upon TCR triggering
and, unlike the potent BH3-only proteins Bim and Puma, its levels
are not highly dependent on the availability of costimulation or
cytokines (9, 15). We summarize the various effects of Noxa on
T cell responses in the following model (Fig. 9): under conditions
of stringent selection, such as during effector cell formation upon
acute infection, the effects of Bim and Puma are dominant (15, 33,
43), causing only increased diversity of the effector pool in ab-
sence of Noxa (Fig. 9A). Memory cell formation is subject to less
stringent selection criteria, and the memory cell pool therefore has
increased clonal diversity compared with the effector cell pool,
also under Noxa-sufficient conditions (24). During this phase,
FIGURE 8. Noxa ablation during persistent T cell activation culminates in lethal pathology. (A) Representative spleens of WT, Noxa2/2, CD70TG, and
Noxa70 mice at 12 wk of age. (B) Kaplan–Meier survival plot for mice of indicated genotypes housed under specific pathogen-free conditions. WT (n = 8),
Noxa2/2 (n = 12), CD70TG (n = 7), Noxa70 (n = 21). (C) Effector/effector memory cell (CD44+CD62L2) numbers in spleen and liver of WT, Noxa2/2,
CD70TG, and Noxa70 mice at 12 wk of age (n = 4–7). (D) H&E analysis of liver sections (original magnification 310, inset 340) from CD70TG and
Noxa70 mice at 15 wk of age, showing increased leukocyte infiltrates in Noxa70 compared with CD70TG mice. (E) Activated caspase-3 and hematoxylin
staining in spleen sections (original magnification 310, inset 340) of mice at 15 wk of age, showing reduced numbers of apoptotic cells (marked by
arrowheads) in Noxa70 compared with CD70TG mice. (F) Cytokine production of CD4 and CD8 T cells from the spleens of WT, Noxa2/2, CD70TG, and
Noxa70 mice, stimulated with PMA/ionomycin in the presence of brefeldin A. Number of IFN-g–producing cells as a percentage of the total CD4 or CD8 T
cell pool is given. *p , 0.05, **p , 0.005, ***p , 0.0005 (Mantel–Cox and one-way ANOVA tests).
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there is less redundancy of BH3-only members and Noxa ablation
results in both increased size and diversity of the memory cell pool
(Fig. 9B) (15, 33, 43). In the case of chronic immune activation,
ample Ag, costimulation, and cytokines are available for activated
T cells, and the role of Bim and Puma in the control of cell numbers
will be even more reduced. In this situation, Noxa has a dominant
role in limiting T cell expansion, and its ablation results in lethal
pathology (Fig. 9C).
From a clinical point of view, our findings may be of interest. An
important goal of new vaccine strategies is to alter the broadness
and size of the immune response (44). A standing question is
therefore whether optimal size and diversity is already inherently
present in the immune system, or whether altered selective pres-
sure on memory cell formation may further enhance or cripple
T cell recall responses. Reducing Noxa-mediated apoptosis during
priming appeared as a promising target to enhance memory
responses. Indeed, ablation of Noxa resulted in a larger and more
diverse memory cell population, and in enhanced T cell expansion
upon reinfection with a similar pathogen.
Interestingly, despite this increased diversity, Noxa2/2 mice
mounted a reduced cross-reactive T cell response. This is un-
expected, as a more diverse memory cell population statistically
has a higher chance of having a high-affinity clone against an
altered epitope. We hypothesize that the difference between
homologous and cross-reactive recall responses results from
differences in selective pressure. During the homologous recall
experiment, high-affinity clones in the primary response form the
most dominant clones in the memory pool and subsequently the
dominant clones in the secondary response (Fig. 2). During
priming in the cross-reactive response, there is no selection for
high-affinity clones that recognize the immunodominant epitope
of the second virus. The clones that dominate the secondary re-
sponse are therefore generally of very low frequency in the memory
population (3). In the homologous response, re-expanding clones
have a numerical advantage over other clones, and interclonal
competition will therefore be of minor influence on their expan-
sion. In the cross-reactive response, competition of low-frequency,
high-affinity memory clones with each other and with naive clones
will occur for limiting nutrients and cytokines (45). We envision
that Noxa mediates this selection process in a similar way as in the
primary response (15). This causes a reduced number of Ag-
specific cells in Noxa-deficient animals during the cross-reactive
response, despite the fact that, because of increased diversity of
the memory cell pool, the precursor frequency of cross-reactive
T cells may even be increased in these mice. However, because
these experiments were performed by analyzing only a limited
number of antigenic epitopes, some caution is warranted in
extrapolating the results to the entire memory response. Future
models, in which expression of Noxa can be regulated, must
reveal whether reduction of Noxa-mediated memory cell se-
lection is actually beneficial to cross-reactive recall responses
when it only occurs during priming.
An additional finding of clinical importance is the observation
that ablation of Noxa under conditions of high-grade T cell acti-
vation did not simply lead to a passive accumulation of effector
memory cells, but resulted in liver and lung destruction (Fig. 8).
This phenotype is distinct from other knockout mice that accu-
mulate large numbers of lymphocytes, such as the FAS/Bim
double knockout (11, 46–48). Interestingly, during acute infec-
tion models, we did not observe increased immunopathology in
Noxa2/2 mice. However, Noxa expression appeared to be highest
in activated cells and went down in memory cells. In accordance
with our model described earlier, this nonredundant role of Noxa
in the control of effector cell numbers and function may therefore
only become obvious under conditions of high or continuous an-
tigenic pressure. Alternatively, the enhanced effector cell numbers
during chronic mCMV infection and in Noxa70 mice may be the
result of reactivation of increased numbers of memory cell pre-
cursors formed in the absence of Noxa.
In Noxa70 mice, we used CD27 stimulation by transgenic
CD70 as a model to test whether a reduced threshold for activated
T cell survival can lead to pathology. Increased CD70 expression
has been well documented, however, in a variety of human dis-
eases such as HIV infection and systemic lupus erythematosus
(49). The fact that Noxa ablation induced T cell accumulation
both under conditions of chronic CD27 stimulation and in a
model for chronic infection with mCMV virus indicates that
proper control of Ag-experienced T cell numbers by Noxa may be
relevant for human disease.
In conclusion, Noxa appears to limit cell numbers both during
effector and memory CD8 T cell formation. Its role in effector cell
formation restricts survival of low-affinity cells, ensuring per-
sistence of effective cells only. In the process of memory cell
formation, Noxa controls memory cell numbers, whereas its
effect on affinity is less pronounced. Re-encounter of Ag in
Noxa2/2 mice thus leads to enhanced effector cell formation, but
lethal pathology after chronic immune activation. A proper control
of apoptotic molecules therefore appears to be essential for ef-
fector and memory T cells to maintain the fine balance between
too few and too many cells upon pathogen encounter and re-en-
counter.
FIGURE 9. Model of the context-dependent effects of Noxa on T cell
expansion. Noxa expression is induced by TCR triggering, and its selective
pressure on activated T cell populations will be similar in different sit-
uations. However, because of changing contributions of Bim and Puma,
Noxa ablation has different consequences. (A) During effector cell for-
mation upon acute infection, available nutrients and cytokines are re-
stricted, and redundancy between the BH3-only proteins Noxa, Bim, and
Puma prevents excessive T cell expansion. Absence of Noxa only results in
enhanced diversity of the effector pool. (B) Selection of activated T cells
into the memory cell pool is less stringent, allowing more clones to con-
tribute to this population. Because of reduced pressure from other BH3-
only molecules, absence of Noxa results both in a larger and more diverse
memory population. (C) In the continuous presence of Ag, expansion is
even less restricted, resulting in a greatly increased number of effector
cells. Absence of Noxa results in enhanced expansion of all cells. Note that
colors of cells denote different clones.
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